Association of lipid-lowering drug treatment with all-cause and cardiovascular mortality among people aged 75 years and above without cardiovascular disease: evidence from a cohort study

Back

ESC Professional Premium Access

Association of lipid-lowering drug treatment with all-cause and cardiovascular mortality among people aged 75 years and above without cardiovascular disease: evidence from a cohort study

Session: Drug therapy (2)

Topic: Drug therapy

Speaker: Assistant Professor Z. Yang (Shatin, HK)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Assistant Professor Zuyao Yang

The Chinese University of Hong Kong, Shatin (Hong Kong)

0 follower

6 more presentations in this session

Bempedoic acid in clinical practice.

Speaker: Doctor J. Vazquez Reguera (Las Palmas de Gran Canaria, ES)

Efficacy and safety of Alirocumab once-monthly dosing in patients with atherosclerotic cardiovascular disease and without acute coronary syndrome or stroke; an ODYSSEY CHOICE I analysis

Speaker: Doctor C. Bonanad Lozano (Valencia, ES)

LDL on target - strike early and strike strong... just strike...

Speaker: Doctor L. Hamann (Faro, PT)

VICTORION IMPLEMENT: an observational study of the lipid management landscape in Germany

Speaker: Professor O. Weingaertner (Jena, DE)

Analytical approaches to open label extension (OLE) after cardiovascular outocmes trials: Observations from the FOURIER and FOURIER-OLE trials

Speaker: Doctor H. Wang (Newbury Park, US)

Access the full session

Drug therapy (2)

Speakers: Assistant Professor Z. Yang, Doctor J. Vazquez Reguera, Doctor C. Bonanad Lozano, Doctor L. Hamann, Professor O. Weingaertner...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources